Skip to content

Adult Influenza Vaccination Text Message Reminders With Electronic Health Record Alerts

Adult Influenza Vaccination Text Message Reminders With Electronic Health Record Alerts

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02284594
Enrollment
4026
Registered
2014-11-06
Start date
2014-11-30
Completion date
2015-03-31
Last updated
2015-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza

Brief summary

Influenza infection leads to on average 3000-49,0000 deaths and 150,000 hospitalizations annually. While vaccination is the cornerstone of preventing influenza infection, vaccination coverage in adults is low. Latino adults have the lowest coverage rates. Text message reminders have been used successfully for improving influenza vaccination for children. This study will assess the use of text messaging to improve influenza vaccination coverage rates in a largely minority, publicly insured adult population. We will also assess if the patient having received a text message makes the patient more likely to accept vaccination when their provider has received in electronic alert regarding need for influenza vaccination in the electronic health record.

Interventions

BEHAVIORALtext message

series of text messages regarding influenza vaccination

Sponsors

Columbia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \> or = 18 years of age * at least one visit to the AIM clinic during previous 6 months * a cell phone number in the registration system * fluent in English or Spanish

Exclusion criteria

\- Receipt of influenza vaccination during the 2014-2015 influenza season prior to randomization

Design outcomes

Primary

MeasureTime frameDescription
influenza vaccinationup to 5 monthsreceipt of influenza vaccine

Secondary

MeasureTime frameDescription
influenza vaccinationup to 2 monthsreceipt of influenza vaccine
captured opportunityup to 5 monthsreceipt of influenza vaccination during a visit

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026